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Abstract
Estimating the lengths-of-stay (LoS) of hospitalised COVID-19 patients is key for predicting
the hospital beds’ demand and planning mitigation strategies, as overwhelming the healthcare
systems has critical consequences for disease mortality. However, accurately mapping the
time-to-event of hospital outcomes, such as the LoS in the intensive care unit (ICU), requires
understanding patient trajectories while adjusting for covariates and observation bias, such as
incomplete data. Standard methods, such as the Kaplan-Meier estimator, require prior
assumptions that are untenable given current knowledge. Using real-time surveillance data
from the first weeks of the COVID-19 epidemic in Galicia (Spain), we aimed to model the
time-to-event and event probabilities of patients’ hospitalised, without parametric priors
and adjusting for individual covariates. We applied a non-parametric mixture cure model
and compared its performance in estimating hospital ward (HW)/ICU LoS to the perfor-
mances of commonly used methods to estimate survival. We showed that the proposed
model outperformed standard approaches, providing more accurate ICU and HW LoS esti-
mates. Finally, we applied our model estimates to simulate COVID-19 hospital demand
using a Monte Carlo algorithm. We provided evidence that adjusting for sex, generally over-
looked in prediction models, together with age is key for accurately forecasting HW and ICU
occupancy, as well as discharge or death outcomes.
Introduction
As of January 2021, SARS-CoV-2 transmission continues to increase in most countries world-
wide [1], and in those countries where control has been achieved, resurgences are expected [2]
before effective vaccines are widely available. Within the main challenges of the pandemic,
overwhelming the healthcare systems has critical consequences on disease mortality [3].
Thus, understanding and predicting inpatient lengths-of-stay (LoS) and critical-care demand
remain some of the major components of outbreak monitoring for decision-making and con-
tingency planning.
Predicting hospital demand entails estimating a patient’s LoS and the probability of hos-
pital outcomes such as requiring admission to the intensive care unit (ICU). Estimation of
these variables is challenging as it requires investigating the patients’ trajectories, and it
must account for complexities in the data. For example, the LoS of some inpatients may be
censored because the study ends before the patient leaves the hospital facility. The LoS of
COVID-19 patients has been studied using parametric models [4], semi-parametric methods
[5] and non-parametric estimators [3, 6].
Parametric and semi-parametric approaches are often preferred due to their simplicity and
ease of interpretation, but they require the LoS to conform to a predefined fixed model.
Estimations based on non-validated assumptions can be significantly biased. Thus, non-
parametric approaches, which do not require model assumptions, should be used when esti-
mating COVID-19 LoS in the absence of solid knowledge.
The Kaplan-Meier (KM) estimator [7] is the simplest and most frequent non-parametric
estimator in medical time-to-event data. It assumes that all patients with missing outcomes
would experience the event in the end. This assumption applies when analysing the duration
of hospitalisation, that is, the total time in the institution of the hospital (which includes time
in hospital ward (HW) and time in ICU), as all patients leave the hospital eventually. However,
this assumption does not apply to a patient’s LoS in the HW until some of the potential out-
comes, such as admission to the ICU or until death, as not all patients need admission to the
ICU or die. Thus, the KM estimator should not be used to estimate those LoS, as it is wrongly
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specified. Alternatively, mixture cure models (MCMs) [8] account
for the situations when a proportion of individuals will not
experience the event being analysed.
Here, we propose a non-parametric MCM (NP-MCM) for esti-
mating the LoS until specific events that are not experienced by all
the patients. Specifically, we computed the following five LoS: LoS
in HW until admission to ICU, LoS in HW until discharge from
HW, LoS in HW until death in HW, LoS in ICU until discharge
from ICU and LoS in ICU until death in ICU. Note that the KM
estimator would not be biased to model the LoS until discharge
if all status on discharge were gathered as a composite outcome.
Although only the first LoS is necessary to model ICU demand,
the other LoS are also of interest, as they are useful to estimate
the conditional probability that a patient experiences each of
those events according to the corresponding observed LoS.
Finally, we also estimated the probability of each event.
First, to illustrate how our model improves data fitting, we
compared the NP-MCM to the KM estimator (which assumes
that all the individuals will experience the event) and to the
empirical (E) estimator (which discards all observations which
event is not observed) for a dataset of COVID-19 patients from
the first weeks of the epidemic in Spain. We further simulated
inpatient and critical care incidence during an outbreak, along
with the final outcome (discharge or death), using the estimated
values and adjusting for age and sex. Our model shows the




The dataset contains 10 454 confirmed COVID-19 cases reported
in Galicia (North-West Spain), from March 6th to May 7th 2020.
Since not all of them required hospitalisation, our study only
included the 2453 patients who were admitted in hospital/ICU
during that period. For the patients with several HW and/or
ICU admissions, the considered LoS was the first recorded one,
that is, the number of days from their first entrance in HW/
ICU until they experienced the outcome of interest. Data were
provided by the regional public health authority, Dirección
Xeral de Saúde Pública [9]. The data included information on
age and sex; the dates of COVID-19 diagnosis, admission to the
hospital and/or ICU and the patient’s last known clinical status.
A summary of the dataset can be found in Supplementary mater-
ial Section S1, see also [10] for other results on this dataset.
Model formulation
MCMs [8], a special case of cure models [11], explicitly model
survival as a mixture of two types of patients: those who will
experience the final outcome and those who will not (known as
‘cured’). Note that here a ‘cured’ individual is defined as being
free of experiencing the event of interest, not necessarily cured
in medical terms. The goal of MCM is to estimate the probability
of experiencing the event and the distribution of the time to the
event. The model is formulated as follows.
Let us denote Y as the time to the event of interest (admission
to ICU, death or discharge), with survival function S(t) = P(Y > t).
Let p = P(Y <∞) be the probability that the event will happen,
and S0(t) = P(Y > t|Y <∞) be the survival function of the indivi-
duals experiencing the event. MCM write the survival function
as S(t) = (1 − p) + pS0(t). Then the probability of the event,
p, and the survival function of the time-to-event, S0(t), can be
estimated using a proper estimator of the survival function, S(t),
and the relations:
p = 1− S(1) and S0(t) = S(t) − (1− p)p (1)
When there is a group of patients known not to experience
the event, the survival function S(t) can be estimated non-





n− i+ 1+∑i−1j=1 x j
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, (2)
where ti is the observed time-to-event of all the patients, di
indicates if the event was observed and xi is the indicator of
whether the event was not observed because it is known it will
never happen. To note, this estimator reduces to the well-known
KM estimator in a classical time-to-event analysis when the event
happens for all patients or when there is no way to identify the
patients who will not experience the event ever.
The estimator of S(t) in (2) is computed with R software [13]
and used to estimate the probability, p, of the event and the
time-to-event survival function S0(t) using the relationships in
(1) for the five LoS aforementioned in the Introduction. Details
on each LoS, along with an R script for the computation of the
different estimators, can be found in the Supplementary material.
The NP-MCM survival estimator of S0(t) is compared to the
KM estimator computed with two different datasets: (i) the com-
plete set of observations, considering all the patients who are
known not experience the event as simply right censored regard-
less if they might experience it in the future or not (complete
KM), and (ii) a reduced dataset, dismissing the patients who
will not ever experience the event (reduced KM). The empirical
(E) estimator, which considers only patients whose final event is
observed and disregards the right censored observations, has also
been considered. The NP-MCM estimator of the probability, p, of
the event was computed using the estimator of S(t) in (2) and the
relationships in (1). The E estimator of p, given by the ratio between
the number of observed events and the total number of patients,
was computed to motivate the proposed NP-MCM estimator of p
(see Supplementary material Section S2 for details).
The NP-MCM estimator of S(t) in (2), the E estimator and the
KM estimator do not incorporate possible covariate effects, such
as sex and age. When the final outcome is experienced by all
the patients, the extension of the KM estimator to handle covari-
ates is the generalised product-limit estimator [14] of the condi-
tional survival function, S(t|x). When the final outcome is not
experienced by all the patients (‘cured’ individuals, all unidenti-
fied) the incorporation of covariates in the estimation of the prob-
ability of the final outcome p(x) and the distribution of the times
until the event S0(t|x) has been studied recently [15–17] and
implemented in the R package npcure [18], which also performs
significance tests for the probability of the event p(x). When the
final outcome is not experienced by all the patients (‘cured’ indi-
viduals, some of them identified as it happens for our COVID-19
data), the extension of these methods for the NP-MCM model to
estimate p(x) and S0(t|x) has been recently addressed [12], where
evidence of the superiority of the NP-MCM over the traditional
methods is shown. These conditional estimators of S(t|x) [14],
2 Ana López‐Cheda et al.
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Fig. 1. Estimates of the survival function of LoS using NP-MCM (thick black line), KM with the complete dataset (thin light grey line), KM with the reduced dataset
(thin dark grey line) and the E estimator (red line) for all the COVID-19 hospitalised cases (n = 2453) in Galicia (Spain), when the LoS is the time of hospitalisation
both in HW and ICU (top left), time in HW until admission to ICU (top right), time in HW until death in HW (middle left), time in HW until discharge (middle right),
time in ICU until death in ICU (bottom left) and time in ICU until discharge from ICU (bottom right). The NP-MCM and KM estimates give the same result for the time
of hospitalisation, and are represented with a single thick black line (top left).
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p(x) and S0(t|x) [12, 15–17] can handle continuous covariates
such as age, using the information from all the individuals to pro-
vide estimates for one single value, e.g. 40 years. Ignoring the
effect of age and sex on these estimates can produce important
bias in the statistical analysis.
COVID-19 outbreak simulation model
We further simulated a COVID-19 outbreak based on the
NP-MCM estimates of the five LoS considered, with two different
models: (1) the simplest possible where the distributions of the
LoS and probabilities of moving from one state (HW, ICU) to
another (HW, ICU, death, discharge) do not depend on individ-
ual covariates; and (2) a more realistic one with the LoS and tran-
sition probabilities depending on the age and sex. For the ease of
computation, the simulated LoS were not generated directly from
the NP-MCM estimates but from the parametric distribution that
best fitted the NP-MCM estimates, specifically, Weibull distribu-
tions (see Supplementary Fig. S4 for the NP-MCM estimates and
their corresponding Weibull counterparts).
The simulated outbreak consisted of N = 1000 infected indivi-
duals. For the i-th infected individual i = 1,…, N we simulated the
sex Gi (0 = male, 1 = female) and the age Ai (years) using the real
distributions of the reported COVID-19 cases in Galicia on
May 7th 2020 (Supplementary Table S1). As not all the infected indi-
viduals required hospitalisation, let H ⊂ {1, …, N} be the infected
subjects admitted to the hospital. The trajectory of every hospitalised
patient i ∈ H was obtained by simulating the transitions between
states (HW, ICU, discharge, death) using the NP-MCM estimated
probabilities. The times in each state were simulated from the
Weibull distributions that best fitted the NP-MCM estimates, both
conditional and unconditional on the age and sex of the patient
(see Supplementary material Section S4 for further details;
Supplementary Figs S4; S5 and S2, Table S3). From the evolution
of all the hospitalised patients, it is straightforward to compute the
number of patients in every state. We simulated 1000 outbreaks of
N = 1000 infected people, so the mean number of patients in a
HW, in the ICU, dead and discharged can be approximated by a
Monte Carlo simulation for each day as a function of time. For sup-
porting the goodness of fit of the conditional model that considers
the age and sex of the patient, the real number of inpatients in the
COVID-19 dataset has been taken as reference, rescaled to N =
1000 infected people.
Results
We first compared the estimates of the LoS using the NP-MCM
estimator with the E estimator, and the KM estimator with the
complete and reduced dataset.
When an event happens for all patients (a.s. ‘leave the hos-
pital’, when all status on discharge gathered as a composite out-
come), KM is not biased and coincides with the NP-MCM,
both of them represented with the one single line in Figure 1
(top left) and Supplementary Figure S2 (top left). The NP-
MCM and KM estimators consider the n = 2453 hospitalised
patients of which 2142 experienced the event (they left the hos-
pital within the study’s timeframe). The E estimator considers
only the 2142 patients who left the hospital, disregarding the
information from the 311 patients still in hospital. This biases
the E estimate towards shorter LoS, as hospitalised patients with
longer LoS are not been included in the estimation.
Furthermore, when the final outcome is experienced by only a
proportion of patients (‘admission to ICU’, ‘death’, ‘discharge’),
the KM (with both the complete and reduced samples) over-
estimates the time-to-event showing longer LoS than the
NP-MCM. The E estimator underestimates the time-to-event
due to right censoring, showing shorter values of LoS as it only
takes into account patients who experienced the event. The
NP-MCM estimates do not suffer from a similar bias [12]. In
fact, this is one of the advantages of using these methods.
Interestingly, we found small differences between the NP-MCM
estimates and the E estimates (Fig. 1 and Supplementary
Fig. S2). The reason might be that the distribution of the LoS
of the dismissed patients in the E estimation (never admitted to
ICU) is similar to that of the patients who required ICU.
Importantly, for the probability of the medical event (admis-
sion from HW to ICU, death, discharge from HW or ICU) we
showed that not correcting for right censoring (i.e. using the E
estimator with only individuals with the observed outcome)
underestimates the true probability, as the event of the right-
censored individuals could be recorded later in time. The
NP-MCM can adjust to right censoring, providing more accurate
estimates. This can be seen when comparing individual probabil-
ities using NP-MCM and E estimators (Table 1). Note that in
Table 1, the probabilities of mutually exclusive outcomes are
not equal to 1. This is because the final outcome (death or dis-
charge) of 42 inpatients still in ICU at the end of the study
remains unknown, as detailed in Supplementary material
Sections S2.4 and S2.5. This inconsistency of the E estimates is
partially corrected by the NP-MCM estimate.
Then, we used the NP-MCM estimator to assess if age and sex
could play a role in the estimates of the time of hospitalisation
(both HW and ICU) and the time in ICU. Figure 2 shows that
the LoS differ significantly between male and female patients,
and between middle-aged (40 years) and older (70 years) patients.
Particularly, we found that middle-aged female patients showed
shorter LoS in both the institution of hospital and the ICU,
whereas older females showed longer LoS in the ICU (but not
in the hospital) compared to their male counterparts.
Finally, we implemented a COVID-19 outbreak simulation of
N = 1000 infected individuals, using the NP-MCM estimates for
the COVID-19 patients in Galicia (Spain) and accounting for
age and sex heterogeneity in the LoS. Figure 3 shows the differ-
ence in the simulated number of inpatients between considering
age and sex (conditional model) or not considering age and sex
of the patient (unconditional model). The higher the curve the
more inpatients the model predicts. The real number of inpatients
in the COVID-19 dataset, rescaled to N = 1000 infected people,
has been added as the reference. We found no large differences
in the expected number of patients dead or discharged, regardless
of age and sex are considered or not. Similarly, no large
Table 1. Estimated probabilities of the different medical events for the
COVID-19 patients in Galicia (Spain) using NP-MCM and empirical estimators
NP-MCM Empirical
Need for ICU 0.0845 0.0828
Death in HW 0.1561 0.1503
Discharge from HW 0.7953 0.7503
Death in ICU 0.2222 0.1963
Discharge from ICU 0.6820 0.6481
HW, hospital ward; ICU, intensive care unit.
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differences were found in the number of patients in ICU during
the first month (until day 30 approximately) of the epidemic.
However, after 1 month, the unconditional model tends to under-
estimate the number of patients in ICU, whereas the conditional
estimation is closer to the real number of ICU inpatients in the
COVID-19 dataset. The findings for the estimated number of
patients in the HW are similar for a period of 2 months. As a
consequence, if the prediction of HW and ICU beds’ demand is
estimated disregarding the sex and age of the patients, those pre-
dictions will be clearly underestimated, mainly in the case of ICU
capacity. The consequences of this wrong forecast of HW and
ICU occupancy are shown in Figure 4. For a range of possible
capacities (15–90 beds in HW, 5–15 beds in ICU), Figure 4
shows the number of days in which the predicted number of
patients exceeds the capacity. As expected, there is a decreasing
trend, since the lower capacity the more days with excess demand.
If age and sex are disregarded for making predictions (uncondi-
tional model), Figure 4 (right) suggests that 11 ICU beds are
enough to avoid overload in the ICU. However, that ICU capacity
will be exceeded for 18 days, and the available ICU beds should be
set to 12 instead to prevent overwhelming of the ICU. Similar
conclusions can be drawn when predicting HW beds demand
in Figure 4 (left). These discrepancies, simulated for N = 1000
infected people, would worsen as the incidence increases. In
Fig. 2. Generalised product-limit estimator [13] of the conditional survival function S(t|x) for the time of hospitalisation, both in HW and ICU (top) and the time in
ICU (bottom), incorporating the effect of the sex (male = black line, female = red line) and the ages 40 years (left) and 70 years (right) for all the COVID-19 hospi-
talised cases (n = 2453) in Galicia (Spain).
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summary, although no large differences are observed in the pre-
dicted number of deaths and discharges, the conditional model
gives more accurate estimates of the HW and ICU beds’ demand.
This leads to a reduction in the number of days when the number
of inpatients exceeds the HW and ICU capacity.
Discussion
We applied a NP-MCM to estimate the time-to-event and event
probabilities, including LoS in HW and ICU and time to death
or discharge. In this study, we demonstrate how the LoS of hospi-
talised COVID-19 patients evolve over time, given age and sex
distributions matching those from our database. The proposed
model outperformed the KM and the empirical estimators
when the outcome is not experienced by all patients.
Importantly, the model can be adjusted for the use of covariates,
which is significant when conditioning for known heterogeneity
in estimating LoS. Particularly, our analysis demonstrates that
adjusting for age and sex is crucial in accurately understanding
ICU LoS and, in turn, forecasting bed demand.
Often studies with incomplete follow-up data on patients
choose to exclude these patients from the study altogether,
which yields biased estimates [19]. Moreover, when forecasting
hospital demand in (near) real time, information related to the
most recent cases is not available, which again leads to right cen-
sored data. We showed that the empirical estimator introduced
significant bias towards longer LoS from HW admission to ICU
admission because it ignores patients in the HW without ICU
admission. Alternately, the KM estimator yields biased estimates
towards longer stays as well when the event is not experienced
by all patients. The reason is that the KM estimator assumes
that if the follow-up time was long enough, much longer stays
would be observed. Therefore, by comparing the NP-MCM
against the KM estimate, we show how biased the results are
when using the KM estimate. This comparison would support
the use of the non-parametric cure model approach, which
Fig. 3. Number of patients in HW (top left), ICU (top right), deaths (bottom left) and discharges (bottom right) computed from 1000 simulated COVID-19 outbreaks
for a period of 200 days, when the LoS are simulated depending on age and sex (blue), and unconditionally ignoring age and sex dependence (red). The real case
counts of inpatients in the COVID-19 dataset from March 6th (day 1) to May 7th 2020 (day 62), rescaled to N = 1000 infected people, are also included for reference
(solid black line).
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diminishes the problem that occurs when not all subjects
experience the event.
Our findings are consistent with previous studies: a recent
systematic review has shown that median overall hospital stays
ranged from 4 to 21 days outside of China [20], whereas our
model estimated a median overall hospital stay of 11 days (IQR:
7–19); the LoS for patients who died in the HW was generally
shorter than those discharged alive (median 7 and 10 days,
respectively). In contrast, our estimates show a different trend
with regards to ICU LoS, with similar median estimates for
both death and discharged (15 vs. 14 days), again consistent
with that reviewed by Rees et al. [20]. Of note, to our knowledge
only two studies have adjusted LoS by age, all showing increased
LoS for increased age, which is consistent with our findings [4,
21]. Furthermore, as far as we know this is the first study showing
the influence of sex in the LoS, which has important implications
for predicting hospital demand (Fig. 2). With regards to predic-
tion models, some approaches adjust estimates based on age
[22, 23], whereas sex has generally been overlooked in hospital
demand forecasting [22, 24, 25].
Noteworthily, multi-state models [26–29] could seem an alter-
native method. Yet, multi-state cure models, in which transitions
into one or more of the states cannot occur for a fraction of the
population, are quite recent and the scarce literature is limited
to semi and parametric models [30, 31]. Applying a non-
parametric multi-state cure model is not straightforward, since
there is no available literature related to this model. As a conse-
quence, multi-state cure models were not used in this paper,
but remain as a potential alternative approach.
Finally, we highlight key limitations of our model: the lack of a
parametric function limits interpretability to a great extent and
complicates handling several covariates simultaneously [32].
Regarding the application of MCM, there must be good evidence
that some individuals in the population will never experience the
event of interest and the follow-up time must be long enough [33].
To date, there has not been developed a reliable method for com-
puting uncertainty (confidence bands) using MCM estimators,
which remains a limitation of our approach. Finally, data on patient
comorbidities, which likely represent an important source of
heterogeneity in the LoS, were not available for the analysis.
Thus, more accurate estimates of the different LoS can be obtained
if more complete datasets are available.
In summary, we implemented an NP-MCM that improved the
standard survival methodology when estimating LoS until final
outcomes that will not happen for all patients. We also found
that the LoS in the ICU is sensitive to age and sex, which in
turn is relevant when forecasting hospital demand in real time
for public health response. We believe our proposed approach
can be easily implemented in other settings and can provide
more accurate estimates of COVID-19 health demand compared
to previous methods.
Supplementary material. The supplementary material for this article can
be found at https://doi.org/10.1017/S0950268821000959.
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(red).
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